GlassScriptPhysician profile
Lauren Miller
NPI 1588901573
$3,908.09
in general payments reported to CMS, 2019-2025
32 companies · $583 in 2025
The $583 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $979 · 2022: $738 · 2023: $774 · 2024: $835 · 2025: $583.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,166 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,166.25 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $777.57 | 2021-2024 | Jardiance |
| Lilly USA, LLC | $410.30 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $311.89 | 2021-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $259.30 | 2021-2023 | |
| Abbvie INC. | $257.89 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $247.13 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Abbott Laboratories | $229.98 | 2024 | Freestyle Libre |
| Dexcom, INC. | $193.36 | 2024-2025 | Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Pfizer INC. | $174.36 | 2021-2025 | |
| Novo Nordisk INC | $166.32 | 2021-2025 | Ozempic, Rybelsus |
| Exact Sciences Corporation | $84.55 | 2023-2024 | Cologuard Collection Kit |
| Boston Scientific Corporation | $81.19 | 2022-2025 | Watchman Access System |
| Astellas Pharma US INC | $78.76 | 2021-2023 | Veozah |
| Amarin Pharma, INC. | $73.79 | 2021 | |
| Amgen INC. | $70.25 | 2021-2023 | Repatha, Otezla |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $67.87 | 2023 | Senza |
| Sanofi Pasteur INC. | $53.15 | 2023 | |
| Currax Pharmaceuticals LLC | $52.68 | 2023 | Contrave, Nexletol, Onzetra Xsail |
| Janssen Pharmaceuticals, INC | $49.80 | 2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $44.38 | 2022-2023 | Camzyos |
| Mylan Specialty L.P. | $32.51 | 2021-2023 | Yupelri |
| Sunovion Pharmaceuticals INC. | $27.72 | 2021 | |
| Merck Sharp & Dohme LLC | $21.85 | 2021 | |
| Eisai INC. | $19.54 | 2021 | |
| Medtronic, INC. | $18.19 | 2024 | Venaseal |
| Novartis Pharmaceuticals Corporation | $17.80 | 2022 | |
| Sanofi-Aventis U.S. LLC | $16.17 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.75 | 2024 | Xifaxan |
| Kowa Pharmaceuticals America, INC. | $14.45 | 2021 | |
| Vistapharm, INC. | $14.38 | 2021 | |
| Si-Bone, INC. | $13.18 | 2021 | |
| Biogen, INC. | $12.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.